Database Query Results : , , IMPDH2
IMPDH2, inosine monophosphate dehydrogenase 2: Click to Expand ⟱
| Source: |
| Type: |
IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways. IMPDH2 expression has been found to be vastly dysregulated in several cancer types, promoting pro-tumorigenic phenotypes and leading to an elevated IMPDH2/IMPDH1 ratio.
Many cancers have high levels of IMPDH2 and is associated with increased tumor proliferation, aggressiveness, and poorer overall survival. Its expression often correlates with a more aggressive tumor phenotype.
|
Scientific Papers found: Click to Expand⟱
aSmase↝, Diablo↑, Fas↓, Hsc70↓, Hif1a↓, Mcl-1↓, HSP90↓, FLT4↓, EphB4↓, DNA-PK↓, PARP1↓, ATM↓, XIAP↝, PLC↓, GnT-V↝, heparanase↝, NM23↑, CSR1↑, SPP1↓, DNMT1↓, HDAC4↓, CXCR4↓, β-catenin/ZEB1↓, FBXW7↝, AMACR↓, cycD1/CCND1↓, IGF-1R↓, IMPDH1↓, IMPDH2↓, HEC1↓, NHE1↓, NOS2↓,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Mitochondria & Bioenergetics ⓘ
XIAP↝, 1,
Core Metabolism/Glycolysis ⓘ
AMACR↓, 1,
Cell Death ⓘ
aSmase↝, 1, CSR1↑, 1, Diablo↑, 1, Fas↓, 1, Mcl-1↓, 1,
Transcription & Epigenetics ⓘ
SPP1↓, 1,
Protein Folding & ER Stress ⓘ
Hsc70↓, 1, HSP90↓, 1,
DNA Damage & Repair ⓘ
ATM↓, 1, DNA-PK↓, 1, DNMT1↓, 1, PARP1↓, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1,
Proliferation, Differentiation & Cell State ⓘ
FBXW7↝, 1, HDAC4↓, 1, IGF-1R↓, 1,
Migration ⓘ
EphB4↓, 1, GnT-V↝, 1, heparanase↝, 1, NM23↑, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
FLT4↓, 1, Hif1a↓, 1,
Barriers & Transport ⓘ
NHE1↓, 1,
Immune & Inflammatory Signaling ⓘ
CXCR4↓, 1,
Cellular Microenvironment ⓘ
PLC↓, 1,
Clinical Biomarkers ⓘ
HEC1↓, 1, NOS2↓, 1,
Functional Outcomes ⓘ
IMPDH1↓, 1, IMPDH2↓, 1,
Total Targets: 32
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: IMPDH2, inosine monophosphate dehydrogenase 2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:411 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page